(Q34481949)

2 August 2017

1 reference

title

Mucoactive drugs for asthma and COPD: any place in therapy? (English)

1 reference

chronic obstructive pulmonary disease

2 August 2017

1 reference

1 reference

Duncan F Rogers

1

1 reference

PubMed ID

11772318

2 August 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

Expert Opinion on Investigational Drugs

2 August 2017

1 reference

2 August 2017

11

1 reference

2 August 2017

1

1 reference

2 August 2017

15-35

1 reference

Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression

2 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Regulation of human airway surface liquid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Airway goblet cells: responsive and adaptable front-line defenders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Physiology and pathology of tracheobronchial glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Airway mucosa: secretory cells, mucus and mucin genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Allelic polymorphism and chromosomal localization of the human oviductin gene (MUC9)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

MUC5B is a major gel-forming, oligomeric mucin from human salivary gland, respiratory tract and endocervix: identification of glycoforms and C-terminal cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Mucus glycoproteins from 'normal' human tracheobronchial secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

The pathology of asthma, with special reference to changes in the bronchial mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

A clinical and pathological study of fatal cases of status asthmaticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Characterization of airway mucus from a fatal case of status asthmaticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Purification, properties, and analysis of human asthmatic bronchial mucin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

ROSETTE-LIKE ARRANGEMENT OF POLYOMA VIRUS PARTICLES IN INFECTED MOUSE-EMBRYO CELLS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Bronchial mucus in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Markers of mucus secretion and DNA levels in induced sputum from asthmatic and from healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Measurement of the bronchial mucous gland layer: a diagnostic yardstick in chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

The size of the bronchial glands in chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Structure of central airways in current smokers and ex-smokers with and without mucus hypersecretion: relationship to lung function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Distribution of bronchial gland measurements in a Jamaican population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

A DISTRIBUTION CURVE FOR CHRONIC BRONCHITIS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Plasma exudation and oedema in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Alteration of airway reactivity by mucus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Enhanced aerosol deposition in the lung with mild airways obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Site and Nature of Airway Obstruction in Chronic Obstructive Lung Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

The natural history of chronic airflow obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Twelve Years Spirometric Changes Among Paris Area Workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Chronic mucus hypersecretion in COPD and death from pulmonary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Effects of drugs on mucus clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Pharmacokinetics of N-acetylcysteine in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Effect of N-acetyl cysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Nacystelyn, a novel lysine salt of N-acetylcysteine, to augment cellular antioxidant defence in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Clinical therapeutic evaluation of methylcysteine hydrochloride in patients with chronic obstructive bronchitis: a balanced double-blind trial with placebo control

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

No demonstrable effect of S-carboxymethylcysteine on clearance of secretions from the human lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

S-carboxymethylcysteine in the fluidification of sputum and treatment of chronic airway obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Effect of the mucoregulator S-carboxy-methyl-cysteine in patients with chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Influence of erdosteine, a mucolytic agent, on amoxycillin penetration into sputum in patients with an infective exacerbation of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

An expectorant, stepronin, reduces airway secretion in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Long-lasting effects on rheology and clearance of bronchial mucus after short-term administration of high doses of carbocysteine-lysine to patients with chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

Changes in mucociliary clearance during acute exacerbations of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

N‐isobutyrylcysteine, a donor of systemic thiols, does not reduce the exacerbation rate in chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.1.15

21 January 2018

Identifiers

DOI

10.1517/13543784.11.1.15

1 reference

2 August 2017

1 reference

PubMed ID

11772318